This one‐year follow‐up study in adult patients with atopic asthma showed that optimized anti‐inflammatory treatment with inhaled corticosteroids and a leukotriene‐receptor‐antagonist resulted in a significant decrease in both total IgE and IgE‐antibody concentrations while exposure to relevant allergens was essentially unchanged. The gene discussed is IGHE; the disease is atopic asthma.